These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. MHC class I antigen presentation of DRiP-derived peptides from a model antigen is not dependent on the AAA ATPase p97. Palmer AL; Dolan BP PLoS One; 2013; 8(7):e67796. PubMed ID: 23844095 [TBL] [Abstract][Full Text] [Related]
8. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? Yewdell JW; Antón LC; Bennink JR J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297 [TBL] [Abstract][Full Text] [Related]
9. The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation. Hahn S; Setz C; Wild J; Schubert U J Immunol; 2011 May; 186(10):5706-18. PubMed ID: 21482733 [TBL] [Abstract][Full Text] [Related]
11. Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action. Lev A; Princiotta MF; Zanker D; Takeda K; Gibbs JS; Kumagai C; Waffarn E; Dolan BP; Burgevin A; Van Endert P; Chen W; Bennink JR; Yewdell JW Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6964-9. PubMed ID: 20351281 [TBL] [Abstract][Full Text] [Related]
12. Plumbing the sources of endogenous MHC class I peptide ligands. Yewdell JW Curr Opin Immunol; 2007 Feb; 19(1):79-86. PubMed ID: 17140786 [TBL] [Abstract][Full Text] [Related]
13. The synthesis of truncated polypeptides for immune surveillance and viral evasion. Cardinaud S; Starck SR; Chandra P; Shastri N PLoS One; 2010 Jan; 5(1):e8692. PubMed ID: 20098683 [TBL] [Abstract][Full Text] [Related]
15. Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection. Cram ED; Simmons RS; Palmer AL; Hildebrand WH; Rockey DD; Dolan BP Infect Immun; 2016 Feb; 84(2):480-90. PubMed ID: 26597986 [TBL] [Abstract][Full Text] [Related]
16. The Effect of Interferons on Presentation of Defective Ribosomal Products as HLA Peptides. Komov L; Melamed Kadosh D; Barnea E; Admon A Mol Cell Proteomics; 2021; 20():100105. PubMed ID: 34087483 [TBL] [Abstract][Full Text] [Related]
17. Quantifying the contribution of defective ribosomal products to antigen production: a model-based computational analysis. Bulik S; Peters B; Holzhütter HG J Immunol; 2005 Dec; 175(12):7957-64. PubMed ID: 16339531 [TBL] [Abstract][Full Text] [Related]
18. Flu DRiPs in MHC Class I Immunosurveillance. Wei J; Yewdell JW Virol Sin; 2019 Apr; 34(2):162-167. PubMed ID: 30456657 [TBL] [Abstract][Full Text] [Related]
19. The role of mRNA translation in direct MHC class I antigen presentation. Apcher S; Manoury B; Fåhraeus R Curr Opin Immunol; 2012 Feb; 24(1):71-6. PubMed ID: 22341517 [TBL] [Abstract][Full Text] [Related]
20. The nature and extent of contributions by defective ribosome products to the HLA peptidome. Bourdetsky D; Schmelzer CE; Admon A Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1591-9. PubMed ID: 24715725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]